Would you have Bronchitis Chronic when you have Multiple Sclerosis?


Bronchitis chronic is found among people with Multiple sclerosis, especially for people who are female, 50-59 old, take medication Avonex and have Headache. We study 63 people who have Bronchitis chronic and Multiple sclerosis from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Multiple Sclerosis

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Copaxone, Tysabri, Avonex, Rebif, Baclofen (latest reports from 423,460 Multiple sclerosis patients)

Bronchitis Chronic

Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic) has been reported by people with osteoporosis, rheumatoid arthritis, high blood pressure, osteopenia, chronic obstructive pulmonary disease (latest reports from 4,825 Bronchitis chronic patients).

On Oct, 21, 2016

63 people who have Multiple Sclerosis and Bronchitis Chronic are studied.

Number of reports submitted per year:

Would you have Bronchitis chronic when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experience Bronchitis Chronic *:

  • female: 88.71 %
  • male: 11.29 %

Age of people who have Multiple Sclerosis and experience Bronchitis Chronic *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4.35 %
  • 30-39: 4.35 %
  • 40-49: 23.91 %
  • 50-59: 47.83 %
  • 60+: 19.57 %

Top co-existing conditions for these people *:

  • Headache (4 people, 6.35%)
  • Type 2 Diabetes Mellitus (3 people, 4.76%)
  • Depression (3 people, 4.76%)
  • Hypertension (2 people, 3.17%)
  • Fibromyalgia (2 people, 3.17%)

Most common drugs for these people *:

  • Avonex (25 people, 39.68%)
  • Tysabri (20 people, 31.75%)
  • Gilenya (7 people, 11.11%)
  • Baclofen (7 people, 11.11%)
  • Aubagio (7 people, 11.11%)

Top symptoms for these people *:

  • Pneumonia (16 people, 25.40%)
  • Cough (11 people, 17.46%)
  • Fall (9 people, 14.29%)
  • Emphysema (9 people, 14.29%)
  • Chronic Obstructive Pulmonary Disease (9 people, 14.29%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Bronchitis chronic and Multiple sclerosis?

Browse all symptoms of Multiple sclerosis

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Bronchitis chronic

Bronchitis chronic

Other conditions that could case Bronchitis chronic

Bronchitis chronic

Related studies

Can you answer these questions?

More questions for: Multiple sclerosis, Bronchitis chronic

You may be interested in these reviews

More reviews for: Multiple sclerosis, Bronchitis chronic

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.